ThyssenKrupp AG’s Neutral Rating Reaffirmed at BNP Paribas (TKA)

BNP Paribas restated their neutral rating on shares of ThyssenKrupp AG (FRA: TKA) in a research note issued to investors on Tuesday, Analyst Ratings.Net reports. The firm currently has a €15.00 ($19.48) price target on the stock.

Several other analysts have also recently commented on the stock. Analysts at HSBC upgraded shares of ThyssenKrupp AG to an overweight rating in a research note to investors on Thursday, May 23rd. They now have a €19.20 ($24.94) price target on the stock. Separately, analysts at Societe Generale upgraded shares of ThyssenKrupp AG to a buy rating in a research note to investors on Thursday, May 16th. They now have a €20.50 ($26.62) price target on the stock. Finally, analysts at Societe Generale reiterated a hold rating on shares of ThyssenKrupp AG in a research note to investors on Wednesday, May 15th. They now have a €18.40 ($23.90) price target on the stock.

Three analysts have rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the company. The stock currently has a consensus rating of Hold and a consensus target price of €18.30 ($23.77).

Shares of ThyssenKrupp AG (FRA: TKA) traded up 3.48% during mid-day trading on Tuesday, hitting €15.78. ThyssenKrupp AG has a one year low of €11.459 and a one year high of €19.25. The stock’s 50-day moving average is currently €17.16.

ThyssenKrupp AG is a Germany-based technology holding company operating through eight business segments.

Latest News

UnitedHealth Group  Price Target Increased to $300.00 by Analysts at BMO Capital Markets
UnitedHealth Group Price Target Increased to $300.00 by Analysts at BMO Capital Markets
VICI Properties  Lifted to “Buy” at Zacks Investment Research
VICI Properties Lifted to “Buy” at Zacks Investment Research
TJX Companies  Stock Rating Upgraded by ValuEngine
TJX Companies Stock Rating Upgraded by ValuEngine
TransDigm Group  Upgraded by ValuEngine to “Buy”
TransDigm Group Upgraded by ValuEngine to “Buy”
Castlight Health Inc  Given Average Recommendation of “Hold” by Analysts
Castlight Health Inc Given Average Recommendation of “Hold” by Analysts
Relx  Earning Favorable News Coverage, Report Shows
Relx Earning Favorable News Coverage, Report Shows


© 2006-2018 Ticker Report. Google+.